Astrana Health Inc (ASTH) financials
Astrana Health revenue and earnings by year
Astrana Health's revenue was $3.18 billion in the fiscal year to December 31, 2025, up 56.4% from the year before. Net income was $22.5 million, 0.7% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 29.7% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.18 | 2.03 | 1.39 | 1.14 | 0.77 | 0.69 | 0.56 | 0.52 | 0.36 | 0.31 |
| Revenue growth | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% | 22.6% | 7.8% | 45.9% | 16.5% | — |
| Gross profit | 0.34 | 0.27 | 0.21 | 0.20 | 0.18 | 0.15 | 0.09 | 0.16 | 0.08 | 0.05 |
| Gross margin | 10.7% | 13.3% | 15.5% | 17.4% | 23.0% | 21.5% | 16.6% | 30.5% | 23.3% | 16.7% |
| Operating income | 0.08 | 0.09 | 0.08 | 0.10 | 0.10 | 0.08 | 0.03 | 0.09 | 0.04 | 0.01 |
| Operating margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% | 5.8% | 17.0% | 9.9% | 3.8% |
| Net income | 0.02 | 0.04 | 0.06 | 0.05 | 0.07 | 0.04 | 0.01 | 0.01 | 0.03 | 0.01 |
| Net margin | 0.7% | 2.1% | 4.4% | 3.9% | 8.9% | 5.5% | 2.5% | 2.1% | 7.2% | 3.7% |
| Diluted EPS | $0.46 | $0.90 | $1.29 | $0.98 | $1.51 | $1.01 | $0.37 | $0.29 | $0.90 | — |
| Free cash flow | 0.10 | 0.04 | 0.04 | 0.06 | 0.05 | 0.05 | 0.01 | 0.02 | 0.05 | 0.02 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ASTH in Markets.
How Astrana Health makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Health Care Capitation Revenue | $906M | 93.1% |
| Health Care Patient Service | $23.0M | 2.4% |
| Health Care Other | $21.8M | 2.2% |
| Management Service | $13.2M | 1.4% |
| Product & Service Other | $8.71M | 0.9% |
See also: ASTH valuation and P/E history · ASTH returns
No forecast, no recommendation. This page describes Astrana Health Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.